Spero Therapeutics Inc. (SPRO)
0.87
-0.02 (-2.25%)
At close: Mar 27, 2025, 3:58 PM
0.83
-4.66%
After-hours: Mar 27, 2025, 07:55 PM EDT
Spero Therapeutics Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| Revenue | 47.98M | 96.73M | 48.58M | 18.26M | 9.33M | 4.74M | 3.97M | 1.98M | 335K | n/a |
| Cost of Revenue | n/a | 367K | 1.55M | 1.12M | 67M | 65.78M | 33.88M | 32.87M | 26.33M | 11K |
| Gross Profit | 47.98M | 96.37M | 47.03M | 17.14M | -57.67M | -61.03M | -29.92M | -30.89M | -26M | -11K |
| Operating Income | -73.36M | 21.48M | -42.2M | -87.97M | -79.11M | -63.22M | -42.81M | -41.73M | -33.22M | -13.33M |
| Interest Income | 4.74M | 3.94M | 1.11M | 346K | 401K | 1.33M | 1.14M | 303K | n/a | n/a |
| Pretax Income | -68.57M | 25.4M | -46.41M | -89.76M | -78.28M | -60.92M | -41.66M | -46.1M | -32.64M | -13.15M |
| Net Income | -68.57M | 22.81M | -48.03M | -91.3M | -77.52M | -60.17M | -41.66M | -46.1M | -25.49M | -10.15M |
| Selling & General & Admin | 23.7M | 25.55M | 36.48M | 41.7M | 21.44M | 15.59M | 12.89M | 10.84M | 7.22M | 2.2M |
| Research & Development | 96.76M | 51.44M | 47.59M | 64.53M | 67M | 65.78M | 33.88M | 32.87M | 26.33M | 11.13M |
| Other Expenses | 877K | -1.74M | -4.93M | -395K | 833K | -13.4M | 1.14M | -4.37M | n/a | 174K |
| Operating Expenses | 121.34M | 75.25M | 79.15M | 106.23M | 88.44M | 67.96M | 42.81M | 41.73M | 33.56M | 13.33M |
| Interest Expense | n/a | n/a | 2.6M | 1.94M | n/a | n/a | 303K | 303K | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 121.34M | 75.25M | 79.15M | 106.23M | 88.44M | 67.96M | 42.81M | 41.73M | 33.56M | 13.33M |
| Income Tax | -68.57M | 2.6M | 1.61M | 1.54M | -761K | -750K | 1.14M | -363K | -7.73M | -3.17M |
| Shares Outstanding (Basic) | 54.04M | 52.7M | 37.59M | 30.9M | 22.39M | 18.16M | 16M | 2.59M | 6.6M | 6.6M |
| Shares Outstanding (Diluted) | 54.04M | 52.99M | 37.59M | 30.9M | 22.39M | 18.16M | 16M | 2.59M | 6.6M | 6.6M |
| EPS (Basic) | -1.27 | 0.43 | -1.28 | -2.96 | -3.46 | -3.31 | -2.6 | -17.82 | -3.86 | -1.54 |
| EPS (Diluted) | -1.27 | 0.43 | -1.28 | -2.96 | -3.46 | -3.31 | -2.6 | -17.82 | -3.86 | -1.54 |
| EBITDA | -73.36M | 25.77M | -42.26M | -87.17M | -76.93M | -62.47M | -42.4M | -41.37M | -32.94M | -13.32M |
| Depreciation & Amortization | n/a | 367K | 1.55M | 1.12M | 1.35M | 1.16M | 409K | 363K | 279K | 11K |